JPH0226567A - Phantom for hyperthermia - Google Patents
Phantom for hyperthermiaInfo
- Publication number
- JPH0226567A JPH0226567A JP63175203A JP17520388A JPH0226567A JP H0226567 A JPH0226567 A JP H0226567A JP 63175203 A JP63175203 A JP 63175203A JP 17520388 A JP17520388 A JP 17520388A JP H0226567 A JPH0226567 A JP H0226567A
- Authority
- JP
- Japan
- Prior art keywords
- phantom
- water content
- hyperthermia
- soln
- high water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Radiation-Therapy Devices (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明はハイパーサーミア用ファントムに関し、更に詳
細には、11!磁波による温熱療法、特に癌の温熱療法
の前臨床に必要な生体組織等価モデルであるハイパーサ
ーミア用ファントムに関する。[Detailed Description of the Invention] <Industrial Application Field> The present invention relates to a phantom for hyperthermia, and more specifically, 11! The present invention relates to a hyperthermia phantom, which is a living tissue equivalent model necessary for preclinical thermotherapy using magnetic waves, especially hyperthermia therapy for cancer.
〈従来の技術〉
「ハイパーサーミア」とは、一般的に「温熱療法」と呼
ばれるものであって1例えば癌治療において、腫瘍部位
の温度を電磁波により41℃以上に加温させることによ
って、該腫瘍部位の殺細胞効果を期待するものである。<Prior art>"Hyperthermia" is generally called "hyperthermia".1 For example, in cancer treatment, the temperature of a tumor site is heated to 41 degrees Celsius or higher using electromagnetic waves. is expected to have a cell-killing effect.
即ち癌におかされていない正常組織では、血管が分布さ
れているので。In other words, blood vessels are distributed in normal tissues that are not affected by cancer.
血流による冷却効果があるのに対し、腫瘍部位は、−1
’!2に血流の循環が悪く、熱がうつ滞し、加温されや
すいこと及び腫瘍部位の温熱感受性は該腫瘍の組織型に
あまり左右されないことに注目して種々研究がなされて
いるものである。While there is a cooling effect due to blood flow, the tumor site has a -1
'! 2. Various studies have been conducted focusing on the fact that poor blood circulation causes heat to stagnate and cause overheating, and that the thermal sensitivity of the tumor site is not significantly influenced by the histological type of the tumor. .
しかしながらハイパーサーミアを実施する場合、解剖学
的に任意の腫瘍部位をできるだけ均一に、一定の温度で
一定時間加温できる装置とその腫瘍内温度分布を正確に
測定し得る温度計測技術が必要であり、現在のところ研
究が進められている段階である。例えば該腫瘍内温度分
布を測定するために、温度計を該腫瘍部位に直接挿入す
る方法等が提案されているが、該温度計を直接刺すとい
う点で医学的に必ずしも好ましいとは言えず、電磁波の
照射条件と温度上昇との関係をあらかじめ知るために、
前臨床的なものとして種々のファントム又は実験動物を
用いることが提案されており。However, when performing hyperthermia, it is necessary to have a device that can heat any anatomical tumor site as uniformly as possible at a constant temperature for a certain period of time, and a temperature measurement technology that can accurately measure the temperature distribution within the tumor. Research is currently in progress. For example, methods have been proposed in which a thermometer is directly inserted into the tumor site in order to measure the temperature distribution within the tumor, but it is not necessarily medically preferable to directly insert the thermometer into the tumor site. In order to know in advance the relationship between electromagnetic wave irradiation conditions and temperature rise,
It has been proposed to use various phantoms or experimental animals for preclinical purposes.
その一部は既に実用化されているが、なお多くの難点が
指摘されている。Although some of them have already been put into practical use, many drawbacks have still been pointed out.
一般に生体組成は電磁波物性が水に似ていることから、
ハイパーサーミア用ファントム素材として、水またはゼ
リー、こんにゃく、寒天等の高含水ゲルが提案されてい
る。In general, biological composition has electromagnetic properties similar to water, so
Water or high water content gels such as jelly, konnyaku, and agar have been proposed as phantom materials for hyperthermia.
しかしながら生体組成の電磁波特性は、加温に使用する
周波数への依存性が高く、従って用いる装置の周波数に
合せたファントム素材の組成調整が必要とされているが
組成調整は、わずかの差によって得られる結果が大きく
異なるため、非常に困難であり、また物性の長期安定性
及び機械的強度に欠けるものが多く、更に含水率が高い
物質であるので腐敗、カビ等が発生しやすいため、再現
性及び長期使用に耐えられないという欠点がある。However, the electromagnetic wave characteristics of biocomposition are highly dependent on the frequency used for heating, and therefore it is necessary to adjust the composition of the phantom material to match the frequency of the device used. It is very difficult to reproduce the results because the results vary greatly, and many materials lack long-term stability of physical properties and mechanical strength.Furthermore, since the materials have a high water content, they are prone to rot and mold, so reproducibility is difficult. Also, it has the disadvantage of not being able to withstand long-term use.
また最近血液等の液体部分を除いたファントムについて
の研究がなされており、例えば筋、皮膚、臓器等の細胞
密度が高く、含水率の高い組織と骨、脂肪等の含水率の
低い組織とに大別し、研究がなされているが、更に細か
い分類での詳細検討が必要とされている。Recently, research has been conducted on phantoms that exclude liquid parts such as blood, and for example, tissues with high cell density and high water content such as muscle, skin, and organs, and tissues with low water content such as bones and fat. Although research has been carried out by broadly classifying them, more detailed examination of finer classifications is required.
更に各組成ごとの伝熱特性についても検討が必要であり
、前記各欠点及び要望を単独に調整し得る物性は現在種
々研究され、一部実用化されているが、全てを同時に解
決するハイパーサーミア用ファントムは全く知られてい
ないのが実状である。Furthermore, it is also necessary to consider the heat transfer characteristics of each composition, and various physical properties that can independently adjust the above drawbacks and requests are currently being researched and some have been put into practical use, but there is a method for hyperthermia that solves all of them at the same time. The reality is that the Phantom is completely unknown.
〈発明が解決しようとする課題〉
本発明の目的は、電磁波加温における電磁気特性の周波
数依存性を容易に調整し、電磁気特性が生体の各組織と
等価であり、且つ伝熱特性をも同時に生体各組織と等価
とすることができるハイパーサーミア用ファントムを提
供することにある。<Problems to be Solved by the Invention> The purpose of the present invention is to easily adjust the frequency dependence of electromagnetic characteristics in electromagnetic wave heating, to make the electromagnetic characteristics equivalent to each tissue of the living body, and to simultaneously improve the heat transfer characteristics. An object of the present invention is to provide a phantom for hyperthermia that can be made equivalent to each tissue of a living body.
本発明の他の目的は、長期安定性及び機械的強度に優れ
、しかも反復使用に際しての再現性にも優れたハイパー
サーミア用ファントムを提供することにある。Another object of the present invention is to provide a phantom for hyperthermia that has excellent long-term stability and mechanical strength, as well as excellent reproducibility upon repeated use.
く課題を解決するための手段〉
本発明によれば、けん化度95モル%以上、平均重合度
1,000以上のポリビニルアルコールを含み、且つ、
該ポリビニルアルコールの濃度が8wt%を超え、50
wt%以下の水溶液であって、所定の生体組織の含水量
と同一の含水量並びに所定の電磁波加温機の周波数に合
致する電解質物質量を含有させた水溶液を、任意形状の
成型用鋳型へ注入後、これを−10℃以下の温度に冷却
・固化・成型し1次に、これを解凍する一連の凍結・解
凍操作を少くとも1回行なうことにより得られる高含水
ゲル、もしくは、前記冷却・固化体を融解させることな
く、これに、脱水率(固化・成型体の重量減少率)3w
t%以上の真空・部分脱水を施すことにより得られる高
含水ゲルからなるハイパーサーミア用ファントムが提供
される。Means for Solving the Problems> According to the present invention, a polyvinyl alcohol having a saponification degree of 95 mol% or more and an average polymerization degree of 1,000 or more, and
The concentration of the polyvinyl alcohol exceeds 8 wt% and 50
An aqueous solution containing an electrolyte substance having a water content equal to the water content of a predetermined biological tissue and a predetermined frequency of an electromagnetic wave heating machine, which is less than or equal to wt%, is placed in a mold for forming an arbitrary shape. After injection, the gel is cooled to a temperature of -10°C or lower, solidified, molded, and then thawed. A high water content gel obtained by performing a series of freezing and thawing operations at least once, or the above-mentioned cooling・Without melting the solidified body, the dehydration rate (weight reduction rate of solidified/molded body) is 3w.
A phantom for hyperthermia is provided which is made of a high water content gel obtained by vacuum/partial dehydration of t% or more.
以下本発明を更に詳細に説明する。The present invention will be explained in more detail below.
本発明のハイパーサーミア用ファントム素材は。The phantom material for hyperthermia of the present invention is:
けん化度95モル%以上、好ましくは98モル%以上で
あり、重合度が1 、000以上のポリビニルアルコー
ルを含む水溶液を使用する。該ポリビニルアルコールの
水溶液中の濃度は、8wt%を超え、50wt%以下で
あり、該ポリビニルアルコールに対する含水率を調整す
ることにより、所定の生体組織の含水量と同一の含水量
組成を容易に調製することができる。具体的には前記ポ
リビニルアルコール水溶液は、後述のゲル化を行う際の
部分脱水を除けば、最初の含水率を!Ii整することに
よって所定の生体組織と同一の含水率とすることが可能
であり1例えば皮膚の含水率は、51〜691%、以下
尿管58wt%1項靭58wt%、アキレス鍵63wt
%、舌60〜68vt%、前立腺69〜76wt%、水
晶体67〜70t*t%、肝臓70〜’17wt%。An aqueous solution containing polyvinyl alcohol having a saponification degree of 95 mol % or more, preferably 98 mol % or more and a polymerization degree of 1,000 or more is used. The concentration of the polyvinyl alcohol in the aqueous solution is more than 8 wt% and less than 50 wt%, and by adjusting the water content with respect to the polyvinyl alcohol, a water content composition that is the same as the water content of a predetermined biological tissue can be easily prepared. can do. Specifically, the polyvinyl alcohol aqueous solution has an initial water content of 100%, except for partial dehydration during gelation, which will be described later. By adjusting the water content, it is possible to have the same water content as that of a given biological tissue.1 For example, the water content of the skin is 51 to 691%, below, the ureter is 58 wt%, the toughness is 58 wt%, and the Achilles key is 63 wt%.
%, tongue 60-68vt%, prostate 69-76wt%, lens 67-70t*t%, liver 70-'17wt%.
胃80wt%、膵1175wt%、小腸80wt%、骨
格筋79〜80wt%、子宮80wt%、胸腺82wt
%、膀胱82wt%、腎111178〜81wt%等に
準じて生体組織に合致した含水率を調整することができ
る。Stomach 80wt%, pancreas 1175wt%, small intestine 80wt%, skeletal muscle 79-80wt%, uterus 80wt%, thymus 82wt%
%, bladder 82 wt%, kidney 111178-81 wt%, etc., the water content can be adjusted to match the living tissue.
このように含水率を調整することにより、所定の生体組
成が示す電磁波物性、即ち比誘電率、導電率、熱伝導度
、比熱、硬度等を類似させることもできる。しかしなが
ら、電磁波による生体の加温は、周波数により異なるも
のであるため、使用する電磁波加温機の周波数に応じて
、前記ポリビニルアルコール水溶液の誘電率と電気伝導
度とを調整する必要がある。該調整は、電解質物質の量
を調整して添加することによりあらゆる周波数において
も所定の生体組織と同等な条件にて加温することが可能
となる。前記電解質物質としては、例えば塩化ナトリウ
ム、塩化カリウム等を好ましく挙げることができ、該電
解質物質の添加量は、使用する周波数及び対象となる生
体組織により異なるが、筋肉の場合を例にとれば1例え
ば使用する電磁波加温機の周波数が8MH,の場合には
、前記ポリビニルアルコール水溶液に対して該電解質物
質を0.50〜0.60wt%、13 、 56 MH
zの場合は0.70〜0.75wt%、27.12M)
I、の場合は0.75〜0.82wt%、 433.9
2MHzの場合は0.85〜0.92wt%、915M
H。By adjusting the water content in this way, it is also possible to make the electromagnetic wave physical properties exhibited by a predetermined biological composition, such as relative dielectric constant, electrical conductivity, thermal conductivity, specific heat, hardness, etc., similar. However, since the heating of a living body by electromagnetic waves differs depending on the frequency, it is necessary to adjust the dielectric constant and electrical conductivity of the polyvinyl alcohol aqueous solution according to the frequency of the electromagnetic wave warming machine used. In this adjustment, by adjusting and adding the amount of electrolyte substance, it becomes possible to heat under conditions equivalent to a predetermined biological tissue at any frequency. Preferred examples of the electrolyte include sodium chloride, potassium chloride, etc. The amount of the electrolyte added varies depending on the frequency used and the target biological tissue, but in the case of muscle, for example, 1 For example, when the frequency of the electromagnetic wave heating machine used is 8 MH, the electrolyte substance is added to the polyvinyl alcohol aqueous solution at 0.50 to 0.60 wt%, 13, 56 MH.
In the case of z, it is 0.70-0.75wt%, 27.12M)
I, 0.75-0.82wt%, 433.9
For 2MHz, 0.85-0.92wt%, 915M
H.
の場合は1.OO〜1.Lout%又は2.45G11
.の場合は1615〜1.25wt%等に調整すること
により所定の生体組織とほぼ同一な条件にすることがで
きる。In the case of 1. OO~1. Lout% or 2.45G11
.. In this case, by adjusting the content to 1615 to 1.25 wt%, the conditions can be almost the same as those of a given biological tissue.
本発明では、前記周波数に応じて調製した電解質物質を
含むポリビニルアルコール水溶液を、人体模型または人
体局部体表面の形状に適合する任意形状の成形用鋳型へ
注入し、これを−10℃以下の温度に冷却・固化・成形
し、解凍することによって高含水ゲルを得ることができ
る。この際前記解凍処理は、1回でもよいが1機械的強
度に富む素材を望む場合には、前記凍結・解凍操作を反
復して行うことが好ましい。前記反復回数は、9回以上
行っても効果に変化がなく、経済的に不利なので、特に
2〜8回の範囲内で反復操作することが望ましい。In the present invention, a polyvinyl alcohol aqueous solution containing an electrolyte substance prepared according to the frequency is injected into a mold having an arbitrary shape that matches the shape of a human body model or a human local body surface, and the solution is heated to a temperature of -10°C or less. A high water content gel can be obtained by cooling, solidifying, molding, and thawing. At this time, the thawing process may be carried out once, but if a material with high mechanical strength is desired, it is preferable to repeat the freezing and thawing operations. It is particularly desirable to repeat the operation within the range of 2 to 8 times, since there is no change in the effect even if the above-mentioned repetition is repeated 9 times or more, which is economically disadvantageous.
また本発明では、前記解凍・凍結の反復操作の替りに、
冷却固化体を融解させることなく真空・部分脱水をする
ことによっても、ゲルの機械的強度を向上させることが
できる。しかし、ハイパーサーミア用ファントムとして
、特に強固なゲルを得ることは必要でなく、前記真空・
部分脱水における脱水率(冷却・固化ゲルの重量減少率
)は。Furthermore, in the present invention, instead of the repeated operations of thawing and freezing,
The mechanical strength of the gel can also be improved by performing vacuum/partial dehydration without melting the cooled solidified material. However, as a phantom for hyperthermia, it is not necessary to obtain a particularly strong gel;
What is the dehydration rate (weight reduction rate of cooled and solidified gel) in partial dehydration?
3wt%以上、好ましくは3〜35wt%の範囲である
ことがゲルの形態保持性、加工性の観点から望ましい。It is desirable that the content be 3 wt% or more, preferably in the range of 3 to 35 wt%, from the viewpoint of gel shape retention and processability.
前記真空・部分脱水とは、減圧下において脱水すること
であって、減圧量は特に限定されるものではなく、例え
ば1 ms Hg以下、好ましくは0.lmHg以下、
さらに好ましくは0.O8nnHg以下に減圧すること
が望ましい。この際前記ポリビニルアルコール水溶液の
含水率を求めるには。The vacuum/partial dehydration refers to dehydration under reduced pressure, and the amount of reduced pressure is not particularly limited, for example, 1 ms Hg or less, preferably 0. lmHg or less,
More preferably 0. It is desirable to reduce the pressure to 08nnHg or less. At this time, to determine the water content of the polyvinyl alcohol aqueous solution.
該真空・部分脱水による脱水量をも考慮する必要がある
が、ポリビニルアルコール水溶液の最初の含水率と前記
脱水率との差をとることにより容易にゲル含水率を調製
することができる。Although it is necessary to consider the amount of water dehydrated by the vacuum/partial dehydration, the gel water content can be easily adjusted by taking the difference between the initial water content of the aqueous polyvinyl alcohol solution and the dehydration rate.
本発明において、脂肪、骨等の含水率の低い生体組織を
模すには、前記ポリビニルアルコール水溶液に脂質を混
入し、均一に分散させれば良く。In the present invention, in order to imitate biological tissues with low water content such as fat and bone, lipids may be mixed into the polyvinyl alcohol aqueous solution and uniformly dispersed.
例えば、含水率40%の脂肪組織を模すには、含水率8
0%のポリビニルアルコール水溶液へ等量のレシチンま
たはトリステアリン等を分散させれば良い。更に脂肪分
の多い組織を模すには、脂肪による形態保持性の低下を
避けるために、モノステアリン、トリステアリン等の固
形脂肪を加熱液化して、70℃以上に加熱したポリビニ
ルアルコール水溶液へ添加し、均一に懸濁した後、前記
凍結操作を施すことにより、含水率15〜30wt%の
脂肪組織を模したファントムを製造することができる。For example, to simulate adipose tissue with a water content of 40%,
An equal amount of lecithin or tristearin may be dispersed in a 0% polyvinyl alcohol aqueous solution. Furthermore, in order to simulate fat-rich tissues, in order to avoid deterioration of shape retention due to fat, solid fats such as monostearin and tristearin are liquefied by heating and added to a polyvinyl alcohol aqueous solution heated to 70°C or higher. After the suspension is uniformly suspended, the above-described freezing operation is performed to produce a phantom imitating adipose tissue with a water content of 15 to 30 wt%.
また本発明では、前記脂質以外にポリビニルアルコール
のゲル化を阻害しない成分を好ましくはポリビニルアル
コールの1/2量以下添加することも可能である。前記
ゲル化を阻害しない成分としては、例えばイソプロピル
アルコール、グリセリン、プロピレングリコール、エチ
ルアルコール等のアルコール類、カゼイン、ゼラチン。In the present invention, it is also possible to add, in addition to the above-mentioned lipids, components that do not inhibit the gelation of polyvinyl alcohol, preferably in an amount of 1/2 or less of the amount of polyvinyl alcohol. Examples of the components that do not inhibit gelation include alcohols such as isopropyl alcohol, glycerin, propylene glycol, and ethyl alcohol, casein, and gelatin.
アルブミン等の蛋白質、レシチン、モノステアリン、ト
リステアリン等の脂質、グルコース、寒天。Proteins such as albumin, lipids such as lecithin, monostearin, tristearin, glucose, agar.
カラゲナン等の糖または多tri、 p−ヒドロキシ安
息香酸ブチル、フタロシアニン青、フラバンスロン等の
有機化合物、ニッケル塩、銅塩、マンガン塩、鉄塩、グ
ラファイト、活性炭、シリカ・アルミナ、ゼオライト、
けい酸カルシウム等の無機化合物、無機塩、有機酸塩、
ポリエチレン粉体、アルミナ粉体等を挙げることができ
る。Sugars such as carrageenan or polytris, butyl p-hydroxybenzoate, phthalocyanine blue, organic compounds such as flavanthrone, nickel salts, copper salts, manganese salts, iron salts, graphite, activated carbon, silica/alumina, zeolite,
Inorganic compounds such as calcium silicate, inorganic salts, organic acid salts,
Examples include polyethylene powder and alumina powder.
本発明では、含水率及び電解質物質の量を調製し、前記
一連の操作を施すことにより異なる種々の生体組織を模
した高含水ゲルを得ることができる。該高含水ゲルは、
単独でもハイパーサーミア用ファントムとして使用する
ことができるが、異なる生体組織に模した高含水ゲルを
互いに張り合わせて複合させることもできる。この際接
着剤としてシアノアクリレート系を用いることもできる
が、好ましくは所望含水率のポリビニルアルコール水溶
液を接着面に塗布し、凍結・解凍を施すことが望ましい
。In the present invention, by adjusting the water content and the amount of electrolyte substance and performing the series of operations described above, it is possible to obtain a high water content gel that imitates various different biological tissues. The high water content gel is
Although it can be used alone as a phantom for hyperthermia, it can also be combined by pasting together high water content gels imitating different biological tissues. At this time, a cyanoacrylate adhesive may be used as the adhesive, but it is preferable to apply an aqueous polyvinyl alcohol solution with a desired water content to the adhesive surface, and then freeze and thaw the adhesive.
また本発明では、前記高含水ゲル単独体又は複合体に血
管を模した細管を埋入させることも可能である。該細管
の直径は100μm〜数膿程度とすることができ、血管
と同様に細部にまで埋入させることができる。すなわち
一般に癌細胞には血管がほとんど通っていないので癌に
模した部分以外に前記細管を配設し、恒温器等によって
所定の温度に保たれた液体を細管内部に流すことにより
生体に発生した癌の模型とすることができる。また、前
記血管以外に生体骨格を含む組織を模すことができるほ
か、ゲル内に気管、食道、胃、膀胱、肺、鼻腔、口腔、
尿管、尿道等を模した空間または水分貯留腔を設けるこ
とができ、空気、貯留液、血流などによる電磁波の反射
、散乱、吸収、透過、多重反射状況を検討するためにも
優れたハイパーサーミア用ファントムを得ることもでき
る。Further, in the present invention, it is also possible to embed tubules imitating blood vessels in the high water content gel alone or in the composite. The diameter of the tubule can be about 100 μm to several micrometers, and it can be embedded in even the smallest detail like a blood vessel. In other words, cancer cells generally have almost no blood vessels passing through them, so by placing the above-mentioned tubules in areas other than those imitating cancer cells, and flowing a liquid maintained at a predetermined temperature using a thermostat or the like into the tubules, cancer cells are generated in living organisms. It can be used as a model of cancer. In addition to the above-mentioned blood vessels, it is possible to imitate tissues including biological skeletons, as well as to imitate tissues such as the trachea, esophagus, stomach, bladder, lungs, nasal cavity, oral cavity, etc.
Hyperthermia can create a space or water storage cavity that simulates the ureter, urethra, etc., and is also excellent for examining reflection, scattering, absorption, transmission, and multiple reflection of electromagnetic waves due to air, stored fluid, blood flow, etc. It is also possible to obtain a phantom.
〈実施例〉
以下実施例により、図面を参照して更に詳細に説明する
が1本発明はこれらに限定されるものではない。<Examples> The present invention will be described in more detail below with reference to the drawings using examples, but the present invention is not limited thereto.
去】11L
平均重合度1000.けん化度98.5モル%のポリビ
ニルアルコール(以下PVAとする)39.1重量%と
水60重量%と塩化ナトリウム0.955重量%トラ均
一台り、300X200X5mの直方体成型用鋳型へ注
入した1次いで−2,5℃にて冷却・固化・成型した後
、凍結、解凍処理を2回行い、皮膚組織に模した皮膚用
ファン1−ム1を1枚作製した。得られた皮膚用ファン
トム1は、周波数433.92MH,においで、誘電率
(以下εHとする)押49、電気伝導度(以下σHとす
る)F1.30s/mであった6次いで皮膚用ファント
ム1と同様なPVA15重量%と水34.7重量%とト
リステアリン50重量%と塩化ナトリウム0.45重量
%とを均一混合し、皮膚用ファントム1と同様な方法に
より、 300 X 200 X 10■の脂肪組織に
模した脂肪用ファントム2を2枚作製した。11L Average degree of polymerization 1000. 39.1% by weight of polyvinyl alcohol (hereinafter referred to as PVA) with a saponification degree of 98.5 mol%, 60% by weight of water, and 0.955% by weight of sodium chloride. After cooling, solidifying and molding at -2.5° C., freezing and thawing were performed twice to produce one skin fan 1-m 1 imitating skin tissue. The obtained skin phantom 1 had a frequency of 433.92 MH, an odor, a dielectric constant (hereinafter referred to as εH) of 49, and an electrical conductivity (hereinafter referred to as σH) of F 1.30 s/m. 15% by weight of PVA similar to 1, 34.7% by weight of water, 50% by weight of tristearin, and 0.45% by weight of sodium chloride were uniformly mixed, and in the same manner as skin phantom 1, 300 x 200 x 10 ■ Two adipose phantoms 2 imitating adipose tissue were prepared.
得られた脂肪用ファントム2は、周波数433.92M
H□においてi H45,6,σ)ILr75.3ms
/mであった0次に皮膚用ファントム1と同様なPVA
24.1重量%と水75重量%と塩化ナトリウム0.9
0重量%とを均一混合し、皮膚用ファントム1と同様な
方法により300X200X10mの筋肉組織に模した
筋肉用ファントム3を100枚作製た。得ら九た筋肉用
ファントム3は、周波数433.92M Hzにおいて
iH与53、σH# 1,46s/I11であった。The obtained fat phantom 2 has a frequency of 433.92M.
At H □ i H45,6,σ) ILr75.3ms
PVA similar to 0-order skin phantom 1, which was /m
24.1% by weight, 75% by weight of water, and 0.9% of sodium chloride
0% by weight were uniformly mixed, and 100 muscle phantoms 3 imitating muscle tissue measuring 300 x 200 x 10 m were prepared in the same manner as the skin phantom 1. The obtained muscle phantom 3 had an iH value of 53 and a σH# of 1.46 s/I11 at a frequency of 433.92 MHz.
引続き、前記皮膚用ファントム1.脂肪用ファントム2
及び筋肉用ファントム3を第1図に示すとおり重ね合わ
せ、複合型のハイパーサーミア用ファントムAを作製し
た。得られたファントムAをあらかじめ恒温槽で25℃
に保った後、上下位置にアプリケータ4を夫々設置し、
「ハイパーサーミア・タグメゾシステム」5(米国タグ
メゾ社製、周波数433.92MHz)を用いて斜め方
向に10分間電磁波による加温を行い、サーモカメラと
温度計を併用して、同装置による加温状態を測定・記録
した。次いで、ファントムAを用いて3日毎に1月間同
様の測定を行ったところ得られた値はほぼ同一であり、
得られたハイパーサーミア用ファントムAは、再現性に
優れていることが判明した。Subsequently, the skin phantom 1. fat phantom 2
and muscle phantom 3 were superimposed as shown in FIG. 1 to produce a composite hyperthermia phantom A. The obtained phantom A was heated in advance at 25℃ in a constant temperature bath.
After maintaining the applicator 4 at the upper and lower positions,
Using "Hyperthermia Tagmeso System" 5 (manufactured by Tagmeso, USA, frequency 433.92MHz), heating was performed using electromagnetic waves in an oblique direction for 10 minutes, and a thermo camera and thermometer were used together to measure the heating state by the device. was measured and recorded. Next, when similar measurements were made using Phantom A every 3 days for a month, the values obtained were almost the same.
The obtained hyperthermia phantom A was found to have excellent reproducibility.
夾胤涯l
平均重合度1500、けん化度99.0モル%のPVA
38.9重量%と水60重量%と塩化ナトリウム0.7
5重量%とを均一混合し、長直径280m、短直径18
oIIIlであり、厚さ5m、深さ200+amの楕円
状のドーナツ成型用鋳型へ注入した。次゛いで一20℃
にて冷却・固化・成型した後、凍結、解凍処理を1回行
い皮膚組織に模した皮膚用ファントム1aを作製した。PVA with average polymerization degree of 1500 and saponification degree of 99.0 mol%
38.9% by weight, 60% by weight of water, and 0.7% of sodium chloride.
5% by weight, and the long diameter is 280 m and the short diameter is 18 m.
oIIIl and poured into an oval donut mold with a thickness of 5 m and a depth of 200 am. Next time - 20℃
After cooling, solidifying, and molding, freezing and thawing were performed once to produce a skin phantom 1a imitating skin tissue.
得られた皮膚用ファントム1aは、周波数13.56M
H,において、t 144139.aH’=o、60s
/mであった1次いで皮膚用ファントム1aと同様なP
VA15重量%と水34.7重量%とトリステアリン5
0重量%と塩化ナトリウム0.50重量%とを均一混合
し、長直径270nm、短直径170mmであり厚さ2
0晴、深さ20C)wの楕円状のドーナツ成型用鋳型へ
注入し、皮膚用ファントム1aと同様に脂肪組織を模し
た脂肪用ファントム2aを作製した。得られた脂肪用フ
ァントム2aは、周波数13.56MH,cにおいてE
H〜35.O。The obtained skin phantom 1a has a frequency of 13.56M.
In H, t 144139. aH'=o, 60s
P similar to the skin phantom 1a, which was /m.
15% by weight of VA, 34.7% by weight of water, and tristearin 5
0% by weight and 0.50% by weight of sodium chloride are uniformly mixed, and the long diameter is 270 nm, the short diameter is 170 mm, and the thickness is 2.
The mixture was injected into an elliptical donut mold with a clearness and a depth of 20C) to produce a fat phantom 2a imitating adipose tissue in the same way as the skin phantom 1a. The obtained fat phantom 2a has E at a frequency of 13.56 MH, c.
H~35. O.
σH押26.3ms/mであった0次に、皮膚用ファン
トムlaと同様なPVA23.9重量%と水75重量%
と塩化ナトリウム0.70重量%とを均一混合し、長直
径230m、短直径130mであり深さ200IIlm
の楕円状の成型鋳型へ注入し、皮膚用ファントム1aと
同様な方法により、筋肉組織に模した筋肉用ファントム
3aを作製した。σH pressure was 26.3 ms/m. PVA 23.9% by weight and water 75% by weight, similar to skin phantom la.
and 0.70% by weight of sodium chloride, and the long diameter is 230 m, the short diameter is 130 m, and the depth is 200 m.
A muscle phantom 3a imitating muscle tissue was produced in the same manner as the skin phantom 1a.
得られた筋肉用ファントム3aは、周波数13.56M
H。The obtained muscle phantom 3a has a frequency of 13.56M.
H.
において、lH″F 146 、 ty H40、62
s / mであった。In, lH″F 146 , ty H40, 62
It was s/m.
引続き前記皮膚用ファントム1a、脂肪用ファントム2
a及び筋肉用ファントム3aを第2図に示すとおり組立
て、人体胴部を模した複合型ハイパーサーミア用ファン
トムBを作製した。得られたファントムBを恒温層にて
25℃に調整した後rRFハイパーサーミアシステム」
(オムロン、立石電機株式会社製2周波数13 、56
MH1)を用いて、15分間第2図に示すとおり縦方
向(イ)の方向にウォーターポーラスとアプリケーター
(図示せず)とを設置し加温した0次いで温度計により
ファントムB中の縦方向(イ)に沿った温度分布の関係
を調べ、皮膚用ファントムla、脂肪用ファントム2a
及び筋肉用ファントム3aの加温状態の差を測定した。Subsequently, the skin phantom 1a and the fat phantom 2
A and muscle phantom 3a were assembled as shown in FIG. 2 to produce a composite hyperthermia phantom B imitating the human torso. The obtained phantom B was adjusted to 25°C in a constant temperature layer and then subjected to rRF hyperthermia system.
(Omron, Tateishi Electric Co., Ltd. 2 frequencies 13, 56
A water porous and an applicator (not shown) were installed and heated in the vertical direction (a) as shown in Figure 2 for 15 minutes using a phantom B using a thermometer. Investigating the relationship of temperature distribution along b), skin phantom la and fat phantom 2a.
and the difference in the heating state of the muscle phantom 3a was measured.
その結果を表1に示す。The results are shown in Table 1.
表1 縦方向(イ)からの測定
実施例1にて作製した複合型のハイパーサーミア用ファ
ントムAの上面より45mの深さの位置(筋肉用ファン
トム3内)に癌を想定した。前記癌を模した部位7は直
径50mm、高さ501IIlの円柱形であり、そのま
わりには、第3図及び第4図に示すとおり直径2■の血
管に模した細管6をポンプ10,11及び恒温層!!1
2.13と接続させて、前記癌を模した部位7を除した
筋肉用ファントム3内の細部にまで循環するように配設
した。Table 1 Measurement from the vertical direction (a) Cancer was assumed to be at a depth of 45 m from the top surface of the composite hyperthermia phantom A produced in Example 1 (inside the muscle phantom 3). The cancer-simulating site 7 has a cylindrical shape with a diameter of 50 mm and a height of 501 IIl, and around it, as shown in FIGS. And constant temperature layer! ! 1
2.13, and was arranged so as to circulate to every detail within the muscle phantom 3 excluding the cancer-simulating region 7.
次いで恒温装置12により37℃に保たれた生理食塩水
をポンプ10によって細管6に注入した後。Next, physiological saline maintained at 37° C. by the constant temperature device 12 is injected into the thin tube 6 by the pump 10 .
−度恒温装置13を通し再び37℃に恒温してからポン
プ11により細管6に注入させた。すなわち、37℃に
保たれた生理食塩水がポンプ10及び11を用いて筋肉
用ファントム3内に配設した細管6を循環させた。引続
き、細管6内に37℃の生理食塩水を循環させた状態に
おいて、ファントムAの上下位置にウォーターポーラス
を併用してアプリケータ(図示せず)を夫々設置し、「
RFハイパーサーミアシステム」(オムロン、立石電機
株式会社製2周波数13.56MH,)を用いて垂直方
向に20分間加温した。該加温と同時に温度計により温
度分布を測定した。その結果を表2に示す。The temperature was again maintained at 37° C. through the -°C constant temperature device 13 and then injected into the thin tube 6 using the pump 11. That is, physiological saline maintained at 37° C. was circulated through the thin tube 6 disposed within the muscle phantom 3 using pumps 10 and 11. Subsequently, with physiological saline at 37° C. being circulated in the thin tube 6, applicators (not shown) were installed at the top and bottom of the phantom A using water porous, respectively.
The sample was heated vertically for 20 minutes using an RF Hyperthermia System (Omron, Tateishi Electric Co., Ltd., 2 frequencies, 13.56 MH). At the same time as the heating, temperature distribution was measured using a thermometer. The results are shown in Table 2.
表 2
また同じ装置及び同じ方法を用いて、実際の生体の場合
と加温状態を比較したところ実施例3とほぼ同様な加温
状態が得られた。Table 2 Furthermore, when the heating conditions were compared with those of an actual living body using the same apparatus and the same method, almost the same heating conditions as in Example 3 were obtained.
〈発明の効果〉
本発明のハイパーサーミア用ファントムは、電磁波加温
における電磁気特性の周波数依存性を、電解質物質の量
を調整することにより容易に生体の各組織と等価とする
ことができ、しかも伝熱特性をも同時に生体各組織と等
価とすることができるのでハイパーサーミアの前臨床と
して優れた効果を示す、また多量の水を含むのにもかか
わらず。<Effects of the Invention> The hyperthermia phantom of the present invention can easily make the frequency dependence of electromagnetic characteristics during electromagnetic wave heating equivalent to that of each tissue of the living body by adjusting the amount of electrolyte substance, and also has excellent transmission characteristics. It is also effective as a preclinical hyperthermia because its thermal properties can be made equivalent to those of living tissues, even though it contains a large amount of water.
37℃においても長期安定性及び機械的強度に優れてお
り、反復使用に際しての再現性をも備えているので、経
済的にも非常に有利である。It has excellent long-term stability and mechanical strength even at 37° C., and has good reproducibility upon repeated use, so it is very economically advantageous.
第1図は本発明のハイパーサーミア用ファントムの側面
断面図、第2図は人体胴部を模した楕円状のハイパーサ
ーミア用ファントムの断面図、第3図は細管を配したハ
イパーサーミア用ファントムの正面一部透視断面図、第
4図は細管を配したハイパーサーミア用ファン1−ムの
側面一部透視断面図である。Fig. 1 is a side cross-sectional view of the hyperthermia phantom of the present invention, Fig. 2 is a cross-sectional view of an elliptical hyperthermia phantom imitating the human torso, and Fig. 3 is a front part of the hyperthermia phantom equipped with a thin tube. FIG. 4 is a partially transparent sectional view of a side surface of a hyperthermia fan 1-m in which thin tubes are arranged.
Claims (4)
0以上のポリビニルアルコールを含み、且つ、該ポリビ
ニルアルコールの濃度が8wt%を超え、50wt%以
下の水溶液であって、所定の生体組織の含水量と同一の
含水量並びに所定の電磁波加温機の周波数に合致する電
解質物質量を含有させた水溶液を、任意形状の成型用鋳
型へ注入後、これを−10℃以下の温度に冷却・固化・
成型し、次に、これを解凍する一連の凍結・解凍操作を
少くとも1回行なうことにより得られる高含水ゲル、も
しくは、前記冷却・固化体を融解させることなく、これ
に、脱水率(固化・成型体の重量減少率)3wt%以上
の真空・部分脱水を施すことにより得られる高含水ゲル
からなるハイパーサーミア用ファントム。(1) Saponification degree of 95 mol% or more, average polymerization degree of 1,00
An aqueous solution containing 0 or more polyvinyl alcohol and a concentration of the polyvinyl alcohol exceeding 8 wt% and 50 wt% or less, the water content being the same as that of a predetermined biological tissue, and the water content of a predetermined electromagnetic wave heating machine. After injecting an aqueous solution containing an amount of electrolyte material that matches the frequency into a mold of any shape, it is cooled to a temperature of -10°C or less, solidified, and
A high water-containing gel obtained by performing a series of freezing and thawing operations at least once in which it is molded and then thawed, or a gel with a high dehydration rate (solidification) without melting the cooled and solidified product.・A phantom for hyperthermia made of a high water content gel obtained by vacuum/partial dehydration of 3wt% or more (weight reduction rate of molded body).
ることを特徴とする請求項1記載のフアントム。(2) The phantom according to claim 1, characterized in that a thin tube imitating a blood vessel is embedded in the high water content gel.
管を配設することを特徴とする請求項2記載のフアント
ム。(3) The phantom according to claim 2, wherein the capillary is arranged in a portion of the high water content gel other than a portion simulating cancer.
を複合させてなる請求項1、2又は3記載のフアントム
。(4) The phantom according to claim 1, 2 or 3, which is formed by combining a plurality of the high water content gels imitating different biological tissues.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63175203A JPH0226567A (en) | 1988-07-15 | 1988-07-15 | Phantom for hyperthermia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63175203A JPH0226567A (en) | 1988-07-15 | 1988-07-15 | Phantom for hyperthermia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0226567A true JPH0226567A (en) | 1990-01-29 |
Family
ID=15992097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63175203A Pending JPH0226567A (en) | 1988-07-15 | 1988-07-15 | Phantom for hyperthermia |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0226567A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009036684A (en) * | 2007-08-02 | 2009-02-19 | Chiba Univ | Phantom and measuring device using the same |
| JP2010156894A (en) * | 2008-12-30 | 2010-07-15 | Hitoo Okano | Internal organ model |
| JP2010197637A (en) * | 2009-02-25 | 2010-09-09 | Hitoo Okano | Sheet for testing sharpness of cutlery |
| JP2010204131A (en) * | 2009-02-08 | 2010-09-16 | Hitoo Okano | Manipulation training sheet |
| WO2010126018A1 (en) * | 2009-04-28 | 2010-11-04 | 有限会社聖和デンタル | Organ model |
| JP2010277003A (en) * | 2009-04-28 | 2010-12-09 | Seiwa-Dental Corp | Organ model |
| JP2011008213A (en) * | 2009-05-29 | 2011-01-13 | Hitoo Okano | Blood vessel model |
| WO2011040200A1 (en) * | 2009-09-30 | 2011-04-07 | 有限会社聖和デンタル | Blood vessel model |
| JP2011076035A (en) * | 2009-10-02 | 2011-04-14 | Seiwa-Dental Corp | Organ model |
| WO2016047329A1 (en) * | 2014-09-25 | 2016-03-31 | 富士フイルム株式会社 | Aqueous-gel composition for model of living-body organ and model of living-body organ |
| WO2017010190A1 (en) * | 2015-07-10 | 2017-01-19 | 株式会社寿技研 | Simulated animal organ producing method and simulated animal organ |
| JP2021099249A (en) * | 2019-12-20 | 2021-07-01 | E&Cエンジニアリング株式会社 | Biological tissue-equivalent phantom |
| WO2025037363A1 (en) * | 2023-08-14 | 2025-02-20 | 日本電信電話株式会社 | Skin phantom, component concentration measurement device, and measurement method |
-
1988
- 1988-07-15 JP JP63175203A patent/JPH0226567A/en active Pending
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009036684A (en) * | 2007-08-02 | 2009-02-19 | Chiba Univ | Phantom and measuring device using the same |
| JP2010156894A (en) * | 2008-12-30 | 2010-07-15 | Hitoo Okano | Internal organ model |
| JP2010204131A (en) * | 2009-02-08 | 2010-09-16 | Hitoo Okano | Manipulation training sheet |
| JP2010197637A (en) * | 2009-02-25 | 2010-09-09 | Hitoo Okano | Sheet for testing sharpness of cutlery |
| US20120045743A1 (en) * | 2009-04-28 | 2012-02-23 | Yuugengaisha Seiwadental | Organ model |
| WO2010126018A1 (en) * | 2009-04-28 | 2010-11-04 | 有限会社聖和デンタル | Organ model |
| US11315441B2 (en) | 2009-04-28 | 2022-04-26 | Yuugengaisha Seiwadental | Organ model |
| JP2010277003A (en) * | 2009-04-28 | 2010-12-09 | Seiwa-Dental Corp | Organ model |
| EP2426657A4 (en) * | 2009-04-28 | 2015-03-11 | Yuugengaisha Seiwadental | ORGAN MODEL |
| JP2011008213A (en) * | 2009-05-29 | 2011-01-13 | Hitoo Okano | Blood vessel model |
| US9202389B2 (en) | 2009-09-30 | 2015-12-01 | Yuugengaisha Seiwadental | Blood vessel model comprising polyvinyl alcohol and silica particles |
| US8758797B2 (en) | 2009-09-30 | 2014-06-24 | Yuugengaisha Seiwadental | PVA and silica particle blood vessel model |
| JP2011075907A (en) * | 2009-09-30 | 2011-04-14 | Hitoo Okano | Blood vessel model |
| WO2011040200A1 (en) * | 2009-09-30 | 2011-04-07 | 有限会社聖和デンタル | Blood vessel model |
| JP2011076035A (en) * | 2009-10-02 | 2011-04-14 | Seiwa-Dental Corp | Organ model |
| WO2016047329A1 (en) * | 2014-09-25 | 2016-03-31 | 富士フイルム株式会社 | Aqueous-gel composition for model of living-body organ and model of living-body organ |
| JPWO2016047329A1 (en) * | 2014-09-25 | 2017-05-25 | 富士フイルム株式会社 | Aqueous gel composition for biological organ model and biological organ model |
| WO2017010190A1 (en) * | 2015-07-10 | 2017-01-19 | 株式会社寿技研 | Simulated animal organ producing method and simulated animal organ |
| JPWO2017010190A1 (en) * | 2015-07-10 | 2018-04-19 | 株式会社寿技研 | Simulated animal organ manufacturing method, simulated animal organ |
| US11056021B2 (en) | 2015-07-10 | 2021-07-06 | Kotobuki Medical Inc. | Method for producing simulated animal organ and simulated animal organ |
| JP2021099249A (en) * | 2019-12-20 | 2021-07-01 | E&Cエンジニアリング株式会社 | Biological tissue-equivalent phantom |
| WO2025037363A1 (en) * | 2023-08-14 | 2025-02-20 | 日本電信電話株式会社 | Skin phantom, component concentration measurement device, and measurement method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0226567A (en) | Phantom for hyperthermia | |
| US4958626A (en) | Method for applying electromagnetic wave and ultrasonic wave therapies | |
| Lipkin et al. | Measurement of some thermal properties of human tissues | |
| Koch et al. | Determination of temperature elevation in tissue during the application of the harmonic scalpel | |
| Wang et al. | Histological and biochemical analysis of mechanical and thermal bioeffects in boiling histotripsy lesions induced by high intensity focused ultrasound | |
| Robinson et al. | New materials for dielectric simulation of tissues | |
| Heisterkamp et al. | Critical temperature and heating time for coagulation damage: implications for interstitial laser coagulation (ILC) of tumors | |
| Kramar et al. | Acute microwave irradiation and cataract formation in rabbits and monkeys | |
| Babbs et al. | Theoretical feasibility of vasodilator-enhanced local tumor heating | |
| CN109260472A (en) | Multi-functional temperature sensitive aquagel of one kind and its preparation method and application | |
| Homasson et al. | The operation and efficacy of cryosurgical, nitrous oxide-driven cryoprobe: I. Cryoprobe physical characteristics: Their effects on cell cryodestruction | |
| CN109364018B (en) | A kind of injectable body temperature curing self-controlling hyperthermia magnetic hydrogel and preparation method thereof | |
| CN105427725A (en) | Simulation model for evaluating tumor ablation range through ultrasonic mono-modal image fusion | |
| Yang et al. | High-intensity focused ultrasound ablation: An in vitro agarose gel model | |
| CN105203586B (en) | A kind of colloid brain parenchym preparation method and cranium brain physical model | |
| CN105999267B (en) | Molybdenum disulfide nanodot/polyaniline nanohybrid and preparation method and application | |
| CN109036059B (en) | Optical imitation for simulated laser surgery, die structure and preparation method thereof | |
| CN111724666A (en) | A phantom model for simulating clinical tumor thermal ablation therapy | |
| CN104174122A (en) | Bionic hydrogel assembly for assessment of thermal ablation curative effect, and preparation method | |
| Zhu et al. | Evaluation of the effectiveness of transurethral radio frequency hyperthermia in the canine prostate: Temperature distribution analysis | |
| Zhmakin | Heat transfer in vivo: Phenomena & models | |
| Gill et al. | A look at cryosurgery | |
| Ramajayam et al. | Adjuvant-perfluorocarbon based approach for improving the effectiveness of cryosurgery in gel phantoms | |
| CN107057088B (en) | A kind of preparation method of convenient and fast high-performance collagen gel | |
| JPH0647030B2 (en) | Pseudo-biological structure for physical therapy |